Rituximab therapy for AA-amyloidosis secondary to rheumatoid arthritis.
Javier
J
Narváez
Maria Victoria
MV
Hernández
José Miguel
JM
Ruiz
Carmen Gómez
CG
Vaquero
Xavier
X
Juanola
Joan Miquel
JM
Nollaa
D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D000069283:Rituximab; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab